SCOTT G SULLIVAN

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant|Medical PANAMA CITY, FL NPI 1750440004

General Payments — all program years on this page

$881.87

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 55
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $401.46 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $401.4622

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $125.227
2023 $355.1926
2024 $401.4622

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1082670717 Neos Therapeutics, LP $18.92 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087324051 Novartis Pharmaceuticals Corporation $14.26 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100301553 Novo Nordisk Inc $16.22 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100593104 Novo Nordisk Inc $21.13 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104372093 AstraZeneca Pharmaceuticals LP $20.64 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104493154 AstraZeneca Pharmaceuticals LP $15.61 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114459201 Exact Sciences Corporation $14.68 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114459208 Exact Sciences Corporation $16.80 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117393860 Amgen Inc. $16.87 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117695345 Amgen Inc. $16.58 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118139156 Boehringer Ingelheim Pharmaceuticals, Inc. $26.22 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119195488 Otsuka America Pharmaceutical, Inc. $21.02 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135863384 Lilly USA, LLC $16.21 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135863388 Lilly USA, LLC $19.20 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135887261 Lilly USA, LLC $15.51 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135962265 Lilly USA, LLC $13.30 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143612218 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.89 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147325667 Mylan Specialty L.P. $18.63 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147351869 Mylan Specialty L.P. $19.76 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147380579 Mylan Specialty L.P. $20.81 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148408312 Axsome Therapeutics, Inc. $20.48 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153385800 Dexcom, Inc. $22.72 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.